Sanofi Genzyme places patients and science at the center of everything it does, driving innovation across complex diseases. As an innovator, the company is committed to advancing treatments in areas including Rare Diseases, Oncology, Rare Blood Disorders, and Immunology.

Sanofi Genzyme is a leader in Multiple Sclerosis research, exemplified by Olipudase alfa, which significantly improved lung function in ASMD patients. Furthermore, we collaborate to advance patient access through partnerships, such as working with the Parkinson's Foundation to provide free genetic testing and counseling. We also champion patient voices, ensuring access to treatment for breast cancer patients. Learn more about our efforts and discover how we are transforming healthcare.